NCT03472911|Completed
Retroclavicular Approach to Infraclavicular Block
Minimum Effective Volume of Bupivacaine 0.5% for Ultrasound-guided Retroclavicular Approach to Infraclavicular Brachial Plexus Block
Loading search results
Minimum Effective Volume of Bupivacaine 0.5% for Ultrasound-guided Retroclavicular Approach to Infraclavicular Brachial Plexus Block
Sponsor study identifier
observational
25
1 country
1
Study Start
January 8, 2018
Actual (reported)Primary Completion
March 1, 2018
Actual (reported)Study Completion
March 15, 2018
Actual (reported)In this study, the primary objective was to estimate the minimum effective volume of bupivacaine 0.5% resulting in successful block in 50% of patients (MEV50) for ultrasound-guided retroclavicular approach to infraclavicular brachial plexus block.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 15, 2018
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 8, 2018
Actual (reported)March 1, 2018
Actual (reported)March 15, 2018
Actual (reported)March 15, 2018
Actual (reported)March 21, 2018
Actual (reported)The minimum effective volume of bupivacaine 0.5% resulting in successful block in 50% of patients (MEV50)
The determination of MEV50 and its 95% confidence interval (CI) was based on the staircase up-and-down method by Dixon and Massey
30 minutes
estimate the minimum effective volume in 95% of patients (MEV95).
30 minutes
The determination of MEV50 and its 95% confidence interval (CI) was based on the staircase up-and-down method by Dixon and Massey.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Adults between 18 and 65 years of age with infraclavicular brachial lexus block for elective elbow, forearm, wrist, or hand surgery , were selected in the study.
Antalya Training and Research hospital
Antalya, 07100, Turkey (Türkiye)
Ali Sait Kavakli, M.D.
Antalya Training and Research Hospital
25 participants (actual enrollment reported by the registry).
First Submitted
March 15, 2018
First Posted
March 21, 2018
Study Start
January 8, 2018
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
March 1, 2018
Actual (reported)Study Completion
March 15, 2018
Actual (reported)Last Updated
May 3, 2018
Record last verified: 2018-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: